Pionyr Immunotherapeutics IPO

www.pionyrtx.com

Pionyr Immunotherapeutics develops cancer immunotherapies that target the tumor microenvironment to enhance the body’s antitumor immunity and ability to combat cancer.

Founded2015
Register for Details

For more details on financing and valuation for Pionyr Immunotherapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Pionyr Immunotherapeutics Ticker Symbol

Pionyr Immunotherapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Pionyr Immunotherapeutics Stock Price

The stock price for Pionyr Immunotherapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Other companies like Pionyr Immunotherapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM